Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

C. difficile in England is on the rise, but why? A sign of a system on the edge and could a new variant push it over?

C. difficile in England is on the rise, but why? A sign of a system on the edge and could a new variant push it over?

FromInfection Control Matters


C. difficile in England is on the rise, but why? A sign of a system on the edge and could a new variant push it over?

FromInfection Control Matters

ratings:
Length:
26 minutes
Released:
Mar 7, 2024
Format:
Podcast episode

Description

In this episode, Martin Talks to Dr Mark Wilcox OBE, Professor of Microbiology at the University of Leeds, Head of Microbiology Research & Development at Leeds University Hospitals NHS Trust and National Clinical Director for Infection Prevention and Control at NHS England. We mull over the possible reasons for the increase in hospital-onset, hospital attributed cases in England, including ribotypes and antibiotic use. Given that the NHS is under great stress, we discuss the damage potential from a ribotype 955 which shares some genetic characteristics with the 027 ribotype that caused so many problems in the UK and worldwide in the early 2000s. One thing that we agree on is that reductions targets (with teeth) have been very successful in the past and should we venture in that direction again?
Information on data collection, hospital and national typing reports for England can be found here: https://www.gov.uk/government/collections/clostridium-difficile-guidance-data-and-analysis#epidemiology
Released:
Mar 7, 2024
Format:
Podcast episode

Titles in the series (100)

We are a group of professionals who work in the field of infectious disease and infection prevention and control. In this podcast series, we discuss new research and issues on the topic of infection prevention and control. We will pick new papers of interest and will discuss them, often with an author of the paper who can give us some insights into the research that go beyond the written paper. Authors will include nurses, doctors, academics, clinicians, administrators and leaders. We should stress that all of our comments relate to our own opinions and that they do not necessarily reflect those institutions and employers that we relate to. We welcome comment, suggestions and ideas.